Clinical and operational implementation of ansuvimab under expanded access for Ebola patients in the Democratic Republic of the Congo
Authors:
- Sabue MulanguSMSabue Mulangu
- Jepsy YangoJYJepsy Yango
- Felicia LipanskyFLFelicia Lipansky
- Gael MukendiGMGael Mukendi
- Donatien KazadiDKDonatien Kazadi
- Celestin TshimangaCTCelestin Tshimanga
- Grace LoboGLGrace Lobo
- Merveilles KankondeMKMerveilles Kankonde
- Mariano LusakibanzaMLMariano Lusakibanza
- Nsengi NtamabyaliroNNNsengi Ntamabyaliro
- Placide MbalaPMPlacide Mbala
- Wendy P. PainterWPWendy P. Painter
Open Access
- 27 September 2026
- journal article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 173
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Ebola Virus Disease: Uniquely Challenging Among the Viral Hemorrhagic FeversOpen Forum Infectious Diseases, 2025
- Antibody Use during an Outbreak of Ebola Virus Disease in the Democratic Republic of Congo, 2020New England Journal of Medicine, 2022
- Ebola Virus Disease Outbreak — Democratic Republic of the Congo, August 2018–November 2019MMWR. Morbidity and Mortality Weekly Report, 2019
- A Randomized, Controlled Trial of Ebola Virus Disease TherapeuticsNew England Journal of Medicine, 2019
- 2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisationThe Lancet Infectious Diseases, 2019
- The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June–October 2014The Journal of Infectious Diseases, 2015